Oct 15, 2014 ... Sandoz, Inc., et al. ... Teva Pharmaceuticals USA, Inc., the manufacturer of the
original drug, sued Sandoz and Mylan and used two different ...
Government contends a price reduction is the only discount exception to the Anti-
Kickback Statute; PhRMA says this interpretation puts companies at risk of ...
May 30, 2013 ... Endo Pharmaceuticals, Inc., et al claims the defendants are liable due to the ...
May 22, 2013; Thomas O'Grady · Drug/Medical Device ... Merck and Organon
USA Inc. asserted that the New Jersey Product Liability Act exclusion of… ...
validity and enforceability of Cephalon's RE'516 patent, in Apotex, I...
Dr Grady has received grant support from Berlex Inc, Eli Lilly and Company, and
Bionovo Inc for ... paid as a consultant to lead a Data and Safety Monitoring
Board for Organon International Inc. ... Rossouw JE, Prentice RL, Manson JE, et
al. .... U.S. National Library of Medicine 8600 Rockville Pike, Bethesda MD,
Dec 20, 2002 ... In two small studies, tamoxifen slightly lowered (Jones et al, 1992) or did not ...
VTE in a factor V Leiden heterozygote (Weitz et al, 1997), but we are unaware ...
partial thromboplastin time assay (Organon Teknika, Durham, NC, USA), ......
Copyright © 1999 - 2016 John Wiley & Sons, Inc. All Rights Reserved.
Dec 16, 2015 ... 50.4%, P < 0.0001), have a greater HIV RNA level (206,011 vs. 145,509 ..... [SD-
008]. 3; P.L. Kimmel, W.O. Umana, S.J. Simmens, et al. ... 7; T.S. Ahuja, M.
Borucki, J. Grady ..... Duke University Medical Center Box 3646, Durham, North
Carolina 27710, USA ... Published by Elsevier Inc. All rights reserved.
Oct 11, 2004 ... Grady DRubin SMPetitti DB et al. .... by factor V Leiden mutation of risk of deep-
vein thrombosis associated with oral contraceptives containing ...
Apr 22, 2005 ... NV Organon, 5340 BH Oss, The Netherlands ... et al., 2003) or even a negative
effect on BMD (Prior et al.,. 2001). .... pendent company (SYNARC, San Francisco
, CA, USA) who also ..... Ensrud KE, Wallace R, Johnson KC, Cummings SR,
Yankov V,. Vittinghoff E and Grady D (2004) Effects of ultralow-dose ...
Jun 11, 2012 ... 6.6±3.1 UI/l (p=0.0126) for FSH and 4.8±2.3 IU/l vs. ..... Our results agree with
previous data in this respect (Hanevik et al. .... with recombinant FSH (GonalF®
from Merck Serono or Puregon® from Organon-Schering ... GENMOD procedure
(SAS Institute Inc., Cary, NC, USA), with the hypothesis of a Poisson ...
Dec 27, 2006 ... H3T IE2; NV Organon (W.d.H.), 5340 BH Oss, The Netherlands; and Organon
International (V.S., F.A.H.), Roseland, New. Jersey 07068 ..... Archer et al. ..... Lev
Sverdlov (Biometrics Department, Organon USA, Inc.) for the sta- .... Grady D,
Gebretsadik T, Kerlikowske K, Ernster V, Petitti D 1995 Hormone.